Fluvastatin suppresses the proliferation, invasion, and migration and promotes the apoptosis of endometrial cancer cells by upregulating Sirtuin 6 (SIRT6)

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
   PubMed Web of Science ®Google Scholar
• Braun MM, Overbeek-Wager EA, Grumbo RJ. Diagnosis and management of endometrial cancer. Am Fam Physician. 2016;93:468–474.
   PubMed Web of Science ®Google Scholar
• McAlpine JN, Temkin SM, Mackay HJ. Endometrial cancer: not your grandmother’s cancer. Cancer. 2016;122:2787–2798.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921.
   PubMed Web of Science ®Google Scholar
• Garwood ER, Kumar AS, Baehner FL, et al. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010;119:137–144.
   PubMed Web of Science ®Google Scholar
• Micheel CM, Sweeney SM, LeNoue-Newton ML, et al.; Consortium APG. American Association for cancer research project genomics evidence neoplasia information exchange: from inception to first data release and beyond-lessons learned and member institutions’ perspectives. JCO Clin Cancer Inform. 2018;2:1–14.
   PubMed Web of Science ®Google Scholar
• Yang Z, Su Z, DeWitt JP, et al. Fluvastatin prevents lung adenocarcinoma bone metastasis by triggering autophagy. EBioMedicine. 2017;19:49–59.
   PubMed Web of Science ®Google Scholar
• Zhang T, Bai R, Wang Q, et al. Fluvastatin inhibits HMG-CoA reductase and prevents non-small cell lung carcinogenesis. Cancer Prev Res (Phila). 2019;12:837–848.
   PubMed Web of Science ®Google Scholar
• Kanugula AK, Dhople VM, Volker U, et al. Fluvastatin mediated breast cancer cell death: a proteomic approach to identify differentially regulated proteins in MDA-MB-231 cells. PLoS One. 2014;9:e108890.
   PubMed Web of Science ®Google Scholar
• You W, Steegborn C. Structural basis for activation of human sirtuin 6 by fluvastatin. ACS Med Chem Lett. 2020;11:2285–2289.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Wada-Hiraike O, Oda K, et al. Putative tumor suppression function of SIRT6 in endometrial cancer. FEBS Lett. 2015;589:2274–2281.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Kanapathipillai M. Treating p53 mutant aggregation-associated cancer. Cancers (Basel). 2018;10. DOI:10.3390/cancers10060154
   PubMed Web of Science ®Google Scholar
• Crowley LC and Waterhouse NJ. Detecting cleaved caspase-3 in apoptotic cells by flow cytometry. Cold Spring Harb Protoc. 2016;2016(11). doi:10.1101/pdb.prot087312 .
   Google Scholar
• Fluvastatin. In: LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD); 2012.
   Google Scholar
• Okubo K, Isono M, Miyai K, et al. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells. Cancer Sci. 2020;111:112–126.
   PubMed Web of Science ®Google Scholar
• Nishiya M, Yasuhira S, Shibazaki M, et al. Fluvastatin exerts an antitumor effect in vemurafenib-resistant melanoma cells. Anticancer Drugs. 2019;30:451–457.
   PubMed Web of Science ®Google Scholar
• Sinzinger H, Wolfram R, Peskar BA. Muscular side effects of statins. J Cardiovasc Pharmacol. 2002;40:163–171.
   PubMed Web of Science ®Google Scholar
• Gertler AA, Cohen HY. SIRT6, a protein with many faces. Biogerontology. 2013;14:629–639.
   PubMed Web of Science ®Google Scholar
• Yang Z, Yu W, Huang R, et al. SIRT6/HIF-1alpha axis promotes papillary thyroid cancer progression by inducing epithelial-mesenchymal transition. Cancer Cell Int. 2019;19:17.
   PubMed Web of Science ®Google Scholar
• Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–159.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Vasudevan P, Zhong L, et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med. 2012;18:1643–1650.
   PubMed Web of Science ®Google Scholar
• Zhu D, Shi C, Jiang Y, et al. Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21 Bioengineered. 2021;12(1): 1505–1516 . DOI: 10.1080/21655979.2021.1916271.
   PubMed Web of Science ®Google Scholar
• Liu K, Xue B, Bai G, et al. Downregulation of diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest. Bioengineered. 2021;12(1):1517–1529.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu Y, Huang Q, et al. SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway. Mol Med Rep. 2019;20:1575–1582.
   PubMed Web of Science ®Google Scholar
• Ouyang L, Yi L, Li J, et al. SIRT6 overexpression induces apoptosis of nasopharyngeal carcinoma by inhibiting NF-κB signaling. Onco Targets Ther. 2018;11:7613–7624.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu A, Yu X, et al. SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway. Oncol Rep. 2017;38:1059–1066.
   PubMed Web of Science ®Google Scholar
• Meter MV, Mao Z, Gorbunova V, et al. SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle. 2011;10:3153–3158.
   PubMed Web of Science ®Google Scholar
• Schointuch MN, Gilliam TP, Stine JE, et al. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecol Oncol. 2014;134:346–355.
   PubMed Web of Science ®Google Scholar
• Jska B, Jt A, Rr A, et al. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth. Gynecol Oncol. 2019;154:432–440.
   PubMed Web of Science ®Google Scholar